Effects of SGLT2 inhibitors on cardiovascular outcomes in patients with stage 3/4 CKD: A meta-analysis (original) (raw)
Fig 4
Effect of SGLT2 inhibitors on cardiovascular death or hospitalization for heart failure in patients with different underlying diseases.
CI: confidence interval; HFpEF: preserved ejection fraction; HFrEF: reduced ejection fraction; ASCVD: atherosclerotic cardiovascular disease.